RADIOIMMUNOASSAY OF TESTOSTERONE AND ESTROGENS IN BLOODSTAINS FOR THE PURPOSE OF SEX IDENTIFICATION by Hilliard, Dennis Charles
University of Rhode Island 
DigitalCommons@URI 
Open Access Master's Theses 
1980 
RADIOIMMUNOASSAY OF TESTOSTERONE AND ESTROGENS IN 
BLOODSTAINS FOR THE PURPOSE OF SEX IDENTIFICATION 
Dennis Charles Hilliard 
University of Rhode Island 
Follow this and additional works at: https://digitalcommons.uri.edu/theses 
Recommended Citation 
Hilliard, Dennis Charles, "RADIOIMMUNOASSAY OF TESTOSTERONE AND ESTROGENS IN BLOODSTAINS 
FOR THE PURPOSE OF SEX IDENTIFICATION" (1980). Open Access Master's Theses. Paper 196. 
https://digitalcommons.uri.edu/theses/196 
This Thesis is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion 
in Open Access Master's Theses by an authorized administrator of DigitalCommons@URI. For more information, 
please contact digitalcommons@etal.uri.edu. 
RADIOIMMUNOASSAY OF TESTOSTERONE AND ESTROGENS 
IN BLOODSTAINS FOR THE PURPOSE OF 
SEX IDENTIFICATION 
BY 
DENNIS CHARLES HILLIARD 
A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE OF 
MASTER OF SCIENCE 
IN 
PHARMACOLOGY AND TOXICOLOGY 
UNIVERSITY OF RHODE ISLAND 
1980 
To whom it may concern. 
Due t ~> a lack in cataloging staff, msny theses ha.ve 
not yet been CDtaloged. Unce.ta.loged theses do not circule,te, 
tlru.s limiting our interlibrary lo .... n services. Until your 
thesis is cataloged, we would appreciate receiving your per-
mission to copy the tl1esis if and when requested on Interlibrary 
Loan. The new copyrigi1t law requires the author's written per-
mission for copying. 
Please complete, sign, ai ·d date the form below. Thank you. 
Yours truly, 
Sylvie. C. Krausse 
Interlibrary Loan Librarian/Bibliographer 
I hereby <~. C 
do/do not 
gr;mt permission to the URI Libre.ry to 
copy my thesis for Interlibrnry Lonn purposes until a circulating 
copy becomes oveileble. 
sie;natu~;J/c: c<.<-< ,·,,t (1 , '- (~1. r!(<' :~c qQ 
Date ·=sC\. S\ . \ l.\ \ \1 ~ () 
L070-9 1978 
rev. 6/79 
MASTER OF SCIENCE THESIS 
OF 
DENNIS CHARLES HILLIARD 
Approved: 
Thesis Committee: 
Dean of the Graduate School 
UNIVERSITY OF RHODE ISLAND 
1980 
SHORT TITLE 
SEXUAL IDENTIFICATION FROM BLOODSTAINS 
ABSTRACT 
The capabilities and the limitations involved in ap-
plying commercially prepared Radioimmunoassay (RIA) Kits, 
for testosterone (T) and estrogen (E) , for the purpose of 
identifying the sexual origin of a bloodstain were examined. 
A total of forty whole blood samples were obtained from 
equal numbers of young healthy male and female volunteers. 
Bloodstains were prepared by absorbing these blood samples 
onto 2 X 2 cm squares of white cotton linen. Two separate 
studies were conducted using these stains. Both studies ex-
amined the fractional recovery of T and E when extracted 
with diethyl ether, the ability of the RIA method to detect 
T and E present in the extract at three bloodstain ages (2, 
30, and 60 days after preparation) and whether a T:E ratio 
could be utilized as a basis for discriminating between male 
and female bloodstain samples. The difference between the 
studies lies in the prior knowledge of the sex of each in-
dividual blood sample. In the first study the sex of each 
blood sample was known, (open study), whereas in the second 
study the individual sex was not known but the number of 
each sex was known (single-blind study). A cross-reactivity 
study was performed to determine the direct interference of 
several commonly used synthetic steroids with the RIAs. 
i 
Significant amounts of T and E were detected in ex-
tracts of most bloodstains. Both the open and single-
blind studies showed that there is a significant difference 
between male and female T:E ratic:s 3nd that this difference 
tends to diminish as the bloodstain age increases. The 
single blind study also showed this method to be at least 
70% accurate when the bloodstain is 2 days old. Cross-
reactivity studies showed only one of the synthetic steroids 
tested reacted significantly with the estradiol antiserum. 
All other tests showed no significant cross-reactivity of 
the synthetic steroids tested with either the estradiol or 
testosterone antiseras. RIA of testosterone and estrogens 
in bloodstains is of practical value in determining the 
sexual origin of a bloodstain. 
ii 
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I. INTRODUCTION 
Forensic serology involves the examination of physical 
evidence of a biological nature and includes the speciali-
ties of immunohemotology, biochemistry, enzymology and hu-
man genetics. Most physical evidence examined by a forensic 
serologist contains bloodstains of an unknown origin. Tra-
ditional approaches to the grouping of bloodstains involves 
a comparison of the genetic markers found in a stain with 
those of the suspect(s) and victim(s) involved in a crime. 
Generally the information obtained from these genetic 
markers which is useful for forensic purposes deals with 
population frequency data. Each antigen or isoenzyme de-
tected in a single bloodstain will decrease the possible 
number of people that might have left a particular stain. 
By using additional marker systems, the forensic scientist 
can reduce that probable percentage dramatically. 
In some instances, such as those crimes in which there 
are no control bloodstains available for comparison, the 
blood grouping data alone are of little value to the inves-
tigators. It is occasionally possible, however, to obtain 
additional information from the stain concerning some phy-
sical characteristics of the individual who left the stain. 
The possibilities of discerning the race, age and sex 
of the individual who left the stain are currently being 
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investigated (Brown, 1977; Garner, 1979 and Wigmore, 1979). 
It is the determination of the sexual origin of a blood-
stain through the quantification of t~e sex hormones: 
Testosterone (T) and Estrogens (E) by radioimmunoassay (RIA) 
techniques, that will be the subject of this study. 
This study will attempt to investigate three major 
questions related to the RIA technique of determining the 
sexual origin of a bloodstain. The first question deals 
with the feasibility of whether commercially available kits 
are sensitive and selective enough to quantitate the amounts 
of each steroid present in a specific area of bloodstained 
material. The quantities that are obtained will then be 
calculated as a ratio of T:E and this final result will be 
used as a basis for discriminating between male and female 
samples in both open and blind studies. Secondly, this 
study will investigate the effect that the age of a blood-
stain has on quantifying the steroids in stains up to 60 
days old. Finally, the question of whether synthetic 
steroids, such as those used in oral contraceptive prepa-
rations, significantly cross-react in either RIA method 
will be examined. 
Testosterone and estrogen are well suited to indicate 
sex based on the well established normal average values 
for each in males and females between 15 and 45 years old. 
According to the protocols contained in each RIA kit (NEN, 
1 -9 
ng--nanogram (l0_12 gram) pg--picogram (10 gram) 
3 
1975, 1976) the normal ranges for testosterone in males and 
1 females are 3-lOng /ml and 0-lng/ml plasma, respectively. 
In a preliminary study only testosterone was assayed 
in stains prepared from whole blood obtained from ten male 
and six female volunteers. Although the results from this 
study demonstrated that sex determination is possible us-
ing only testosterone values, it also showed fluctuations 
in values between individuals of the same sex as well as 
some overlapping of values between sexes. The concurrent 
determination of total estrogens in a stain will hopefully 
stabilize variation between individuals. Also the use of 
the two markers in a ratio form to indicate sex will elim-
inate the need to estimate the volume of blood in the stain 
which is extracted in order to compare amounts per ml of 
blood. 
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II. LITERATURE REVIEW 
Genetic markers currently employed in the forensic lab-
oratory include the ABO, Rh and MN antigen-antibody systems, 
the hemoglobin and haptoglobin polymorphic protein systems, 
and the phosphoglucomutase (PGM) , adenylate kinase (AK) , 
erythrocytic acid phosphatase (EAP) , esterase D (EsD~, aden-
osine deaminase (ADA) , 6-phosphogluconate dehydrogenase (PGD) 
and glucose-6-phosphate dehydrogenase (G-6-PD) polymorphic 
enzyme systems (Culliford, 1971) . These systems were cho-
sen for use in the examination of dried bloodstains because 
they are: 1) genetically controlled; 2) present and de-
tectable in a bloodstain; and 3) supply individualizing in-
formation (Garner, 1979). 
Research of constant interest in forensic serology is 
the development of techniques which enable the researcher 
to detect other marker systems present in a bloodstain. 
Currently under investigation are the methods which detect 
markers capable of supplying information about the race, 
age and sex of the individual who left the stain. Informa-
tion of this type is especially useful in cases where there 
are no control samples available, which renders other blood 
grouping data of little value (Wiqmore, 1979). This in-
formation can, to a limited extent, inform police investi-
gators about the characteristics of the suspect for whom 
they are searching. 
Information concerning the race and age characteris-
tics is obtained through the detection of certain variants 
in the hemoglobin system, which are present in a bloodstain 
(Garner, 1979). The techniques involved in this method 
currently allows the forensic serologist to detect the pre-
sence of three hemoglobin variants: HbS, HbC and HbF. The 
presence of HbS and HbC indicate the stain to be of Negroid 
origin, whereas the presence of HbF indicates the blood to 
be from an infant. 
Determination of the sexual origin of a bloodstain be-
came an active subject of research when Schwinger iri 1971 
applied a fluorescent staining technique, which permits the 
identification of the sex indicating Y-chromosomes in inter-
phase and metaphase nuclei, to cell extracts from a blood-
stain. Since this time several other studies have been pub-
lished which have tested the accuracy or improved on the 
method. Aragones (1973) found there were many interfering 
substances in the method used by Schwinger and he improved 
upon the extraction to eliminate those interferences. How-
ever, in studies which examine the accuracies of this method 
in open and blind studies (Schwinger, 1973, and Wigmore, 
1979) the method was found to be susceptible to erroneous 
identifications, caused by interfering fluorescence and the 
judgment of the observer. This method has been reported to 
be 40-80 % accurate in blind studies (Schwinger, 1973, and 
Wigmore, 1979). 
G 
The development of radioimmunoassay (RIA) techniques, 
which are capable of detecting and quantifying small amounts 
of specific substances, has provided the forensic serolo-
gist with a sensitive and accurate method for confirming 
the presence of particular marker systems in a bloodstain. 
With the recent development of new techniques for producing 
highly specific antibodies against substances of interest 
to the forensic serologist the RIA method has become a po-
tentially powerful tool. 
The application of RIA techniques for steroids in for-
ensic serology was ~eported independently by Brown (1976) 
and Stuver (1976) at the 28th annual meeting of The American 
Academy of Forensic Sciences. In the next year at the 29th 
annual meeting, Brown (1977) and Schehr (1977) independent-
ly announced the further application of steroid RIA tech-
niques in bloodstains for the purpose of sex identification. 
In the same year Moller (1977) published data on his appli-
cation of RIA for detecting morphine in bloodstains. 
Those four reports on the use of RIA for quantifying 
the sex hormones: testosterone, estrogen and progesterone, 
in bloodstains for the purpose of sex identification, form 
the basis of this study. Although these three investi-
gators briefly reported on their efforts with this technique 
there has, as yet, been no formal publication of their 
methods and results. Since the published data on the results 
of RIA utilization for the purpose of identifying the sexual 
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origin of bloodstains is liwited, it is necessary to review 
the literature dealing with the basic principles of the RIA 
methodology and especially the specific techniques involved 
in the RIA of steroids. 
Although the methods involved in the RIA technique are 
generally straightforward it is essential to have a clear 
idea of the principles involved. An essential component of 
the RIA method is the antibody. Antibodies were first recog-
nized by Von Behring (1890) when he determined that immunity 
to diphtheria toxin was dependent upon the ability of a fac-
tor in the blood to inactivate the toxin. He proved that 
this factor resided in the serum and in 1901 he earned a 
Nobel prize for his work with antiserum therapy. Since that 
time antibodies have been used clinically to neutralize bio-
logic macromolecules and recently have been used diagnosti-
cally to measure concentrations of these macromolecules. 
The clinical potential use of antibodies has been greatly 
expanded with the production of antibodies which are directed 
against small molecules of therapeutic and diagnostic inter-
est, such as steroids, prostaglandins, thyroid hormones, 
cyclic nucleotides and certain drugs (Ekins, 1974). 
It is the discriminating ability of antibodies to recog-
nize one particular material as distinct from any other which 
is the basis for their use as an analytical tool in all immu-
nologic methods. Although there is a limitation on an anti-
body's ability to discriminate between similar structures 
there are examples where extremely small alterations in the 
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structure of a molecule will drastically change its binding 
to the antibody. Antibodies are not usually preformed in 
an individual but are produced in response to the entry of 
the foreign material into the body. Material that induces 
an immunoresponse is called an immunogen. The substance 
that is bound by antibodies is called the antigen. Most 
substances are both immunogen and antigen, but these two 
properties are distinct and not all antigens have the abil-
ity to initiate the formation of antibodies (Thorell, 1978). 
Antibodies comprise a group of related proteins in 
blood plasma which are collectively referred to as immuno-
globulins. There are five known types of classes of imrnuno-
globulins: IgG, IgM, IgA, IgD and IgE. The basic structure 
of all immunoglobulins is similar with a pair of large poly-
peptide chains (heavy chains, H), that consist of 446 amino 
acids, each associated with a smaller chain (light chain, L) 
214 aminoacids long (Roit, 1976). The chains are arranged 
in a Y-formation and are joined by disulfide bonds. Each 
immunoglobulin molecule has the ability to bind two antigen 
molecules, one at each of the two binding sites, which are 
located at the outer open end of each pair of H-L-chains. 
Differences in the chemical composition of these two ends 
of the molecules (the variable portions) are the structural 
basis for the differences in the binding characteristics of 
different antibodies. The configuration of this binding 
site can therefore assume such a variety of forms that it 
very specifically fits to the surface of any antigenic 
9 
material. The various types of iillP.lunoglobulins have some-
what different biologic functions. IgG is the quantitative-
ly dominant immunoglobulin in plasma. It is this class of 
immunoglobulin that is usually utilized as the binder in 
immunoassays (Thorell and Larson, 1978). 
The antibodies produced in response to an immunogenic 
stimulus constitute only a very small fraction of the total 
antibody population occurring in the plasma of an animal. 
In most assays, however, there is no need to isolate a par-
ticular fraction from the other antibodies present, since 
the assay system only measures the binding of one particu-
lar radioactive antigen (Playfair, 1974). Other antibodies 
present will not interfere in this binding between the la-
beled antigen and its particular antibody. These mutually 
associated antigens and antibodies are called homologous 
antigen and antibody. In certain assay systems, one may 
utilize antibody that is raised against a different immuno-
genr in this case the antigen and antibody are called 
heterologous. 
Radioimmunoassay (RIA) and related competitive protein-
binding methods began about 20 years ago as a cumbersome 
research methodology in two specialist radioisotope centers 
located in New York and London (Ekins, 1974). These meth-
ods represent a common analytical approach of great sensi-
tivity that has been applied to the measurement of more than 
200 substances, many of which cannot be assayed by other 
techniques. It is essentially impossible to exaggerate the 
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diversity of applications for this methodology. Virtually 
every branch of medical and biological research has been 
affected by these techniques. In particular, endocrinology 
has been greatly enriched by the new knowledge that has 
come as a direct result of RIA methods. These methodolo-
gies are being introduced into clinical medicine at a rapid 
rate, and the growing commercial availability of radioassay 
kits will revolutionize the routine practice of hospital 
and research laboratories (Challand, 1974). 
The term radioimmunoassay was coined by Berson and 
Yalow (1960) to describe their original methodology. How-
ever, this term is . adequate for only a small portion of 
related assays which are being used today. There has been 
an effort to select a descriptive word or phrase that would 
be inclusive of all the various assay types, but it is now 
felt that the proper individual terms be used for describ-
ing a particular assay (Ekins, 1974 and Thorell, 1978). 
The term radioligand assay will be used interchangeably 
with RIA. 
In order to establish a radioligand assay, three pre-
requisites must be met: (1) a receptor must be available 
that specifically binds the ligand (antigen) to be mea-
sured; (2) the ligand must be labeled with a radioactive 
nuclide (radioligand); and (3) separation must be achiev-
able between the ligand bound to the receptor and the ligand 
that is unbound (Thorell, 1978). The RIA generally consists 
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of a competitive type radioligand assay, although a non-
competitive type is sometimes employed. 
The competitive assay is the most common type of pro-
cedure used in RIA. In this case, the . specific receptor 
is an antibody directed against the ligand (antigen) to be 
measured. The ligand is injected into a species of animal 
that sees this substance as foreign (iwmunogenic) and pro-
duces a specific antibody against the ligand. The radio-
ligand is produced by coupling a radioactive nuclide to 
the ligand as a marker so that the ligand can be measured. 
The basic principle of RIA is the competition between the 
radioactive and nonradioactive ligand for a fixed number 
of antibody sites. This interaction is represented sche-
matically in Figure 1. 
If increasing amounts of nonradioactive ligand and a 
fixed amount of radioactive ligand are allowed to react 
with a constant amount of antibody, a decreasing amount of 
radioactive ligand is bound to the antibody. This can be 
considered as a progressive dilution of radioligand bound 
to the receptor, or as a progressive dilution of radio-
active material with nonradioactive material, thereby re-
ducing the specific activity of the ligand bound to the 
receptor. 
There is usually an incubation period for most assays, 
during which time the binding reaction between receptor 
anq ligand comes close to equilibrium. This incubation va-
ries in time and temperature requiring anywhere from 30 
Fig. 1 . Antibody-Antigen Interaction1 
Labeled 
Antigen 
Ag* 
+ 
Specific 
Antibody 
Ab 
+ 
Unlabeled 
Antigen 
Ag 
Unlabeled Antigen-Antibody 
Complex 
AgAb 
1From NEN Protocol, 1975. 
Labeled 
Antigen*-Antibody 
Complex 
Ag*Ab 
i-
i\,; 
Jj 
minutes to 24 hours at 37°C to 4°C. For most assays the 
molar concentration of the receptor is chosen to be about 
the same order of magnitude as the expected concentration 
of the ligand in the unknown sample (Parker, 1976). In 
general, the more dilute the receptor, the more sensitive 
the assay. At these low concentrations, longer incubation 
times are necessary in order to achieve a sufficient inter-
action between ligand and receptor. 
After the binding reaction is completed, the separa-
tion of free from antibody bound antigen must be achieved 
in order to determine the partition of the radioactivity. 
Various techniques have been employed for this purpose 
(Radcliffe, 1974). In many cases the antibody-antigen com-
plex is precipitated out of solution by the addition of a 
saturated ammonium sulphate solution. In some circum-
stances, a second incubation period is required, as in the 
double antibody techniques. When the antigen is a steroid, 
separation is achieved through selective adsorption of the 
free antigen onto dextran coated activated charcoal 
(Kushinsky, 1975). The amount of radioactivity of the 
bound fraction is then determined. There is an inverse 
correlation between the amount of radioactivity bound and 
the concentration of native ligand present in samples. This 
relationship is usually not linear. In order to be able 
to measure the amount of ligand present in an unknown bio-
logic sample, such as plasma or urine, the assay must in-
clude a standard series of tubes that contain known amounts, 
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in sequential increments, of the substance to be assayed 
(Bangham, 1974). Based on the radioactivity bound to the 
receptor in these standards, a standard curve is drawn 
and the amount of unlabeled antigen in a sample can then 
be determined by interpolation from this curve. 
In the noncompetitive assay technique the antibody is 
usually labeled instead of the ligand. These methods are 
particularly useful when the ligand cannot be labeled eas-
ily, as is the case with most viral antigens (Thorell, 
1978). The receptor in this method is coupled to an in-
soluble, solid phase matrix. An additional set of recep-
tors is labeled with radioactivity. In the initial phase 
the solid phase receptor is incubated with the sample con-
taining the ligand to be measured until all ligand is bound 
to this receptor. The second step is to add the additional 
set of radio-labeled receptors which are soluble. This 
radioreceptor will adhere to any bound ligand in the prepa-
ration. The technique requires that the ligand be suf fi-
ciently large enough to have two or more molecular regions 
that can act as combining sites (divalent or polyvalent). 
After the second incubation the matrix is washed to remove 
all nonbound radioactivity. The remaining radioactivity 
bound to the matrix is measured. A standard curve is con-
structed by running a series of standards with known in-
cremental amounts of the ligand. The standard curve for 
this assay is directly proportional to the concentration 
of ligand present; that is, the larger the amount of ligand 
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present, the larger the amount of radioactivity bound to 
the matrix (Thorell, 1978). 
RIA and related clinical methods derive their unique 
usefulness from their very great sensitivity in relation to 
other chemical techniques. This sensitivity is related to 
the extremely sensitive methods for the detection of radio-
activity (Ekins, 1974). It is possible to measure the ra-
d . t' · t 125 I · t't' small as 10-4g (or ioac ive iso ope in quan i ies as 
approximately l0-12M) with good precision. Since the serum 
concentrations of most hormones is on the order of 10-9 to 
10-lOM, detection of hormones at the lowest physiologic 
concentration is now possible. The quality of any assay 
is determined by four factors: sensitivity, specificity, 
precision, and accuracy. Specificity is predominantly a 
property which is dependent on the receptor. It is the 
ability of the assay to measure one specific compound and 
no other. The specificity or lack of it is a major problem 
in some assays. For many biologically important compounds, 
a number of compounds exist with similar chemical struc-
tures. Steroid pormone assays are a prime example where 
this problem occurs (James, 1974). There are many steroid 
derivatives with small differences in structure but with 
marked physiologic differences. In this situation there 
are two means of enabling the accurate measurement of a 
single steroid--the production and selection of highly spe-
cific antisera, which requires significant effort especial-
ly in the formation of a suitable immunogen. However, this 
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cannot be accomplished to the point of exclusion of similar 
substances and therefore the situation is sometimes improved 
by chemical separation to isolate the compound of interest 
from the interfering substances. Solvent extraction, wash-
ing procedures and various types of chromatography are the 
procedures most often used (Thorell, 1974). 
The sensitivity of an assay is limited by two factors: 
the affinity of the receptor and the specific activity of 
the radioligand. The affinity of a receptor reflects the 
energy in binding between the ligand and the receptor, the 
firmness of the binding. To be able to measure minute 
amounts of hormones and other biologic compounds with ade-
quate sensitivity the energy of binding has to be very high. 
This often is the limiting factor for the sensitivity of an 
RIA (Thorell, 1974). 
The specific details involving the production of pro-
per immunogens, specific antibodies, the preparation of the 
radioactive ligands and the kinetics of the antibody-anti-
gen interaction is beyond the scope of this review. They 
are clearly detailed in several excellent reviews on RIA 
and related techniques (Ekins, 1974; Bangham, 1974; Hunter, 
1974; Playfair, 1974; Parker, 1976; Dawson, 1978, and 
Thorell, 1978). Measurement of a substance by the RIA 
technique depends on its ability to compete with a suitably 
labeled compound for a binding site. The nature and type 
of radiolabel influences sensitivity of these assays. The 
h . f d . . 14 d 3 . bl synt esis o compoun s containing C an H suita e as 
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markers in a RIA may be expensive, and in addition their 
specific activity may be so low that undesirably large 
amounts must be used, which will cause a decrease in the 
sensitivity of the assay. Manipulations involved in 3H 
d 14c . an counting, including sample preparation, quenching 
corrections, disposal of organic solvents and other diffi-
culties involved in liquid scintillation counting also make 
use of these types of labels undesirable when alternatives 
are available. 125 I and 131 I have been used for labeling 
tyrosine conjugates of drugs and labeling of some steroids. 
They not only produce labels of high specific activity but 
permit the use of simpler counting methods (Marks, 1974). 
In pharmacology RIA offers a sensitive, precise and 
specific method for measuring concentrations of drugs and 
other significant substances in tissues and blood. This 
allows for research to be conducted into their distribu-
tion, metabolism and pharmacokinetics and, increasingly, 
for monitoring drug therapy (Marks, 1974). For many drugs 
there is no other means available to permit accurate mea-
surements under 9linical conditions, so that for even for 
well established drugs such as morphine, virtually no in-
formation had been available concerning its concentration 
in blood under optimum therapeutic conditions. Radioimmuno-
assay techniques which have currently been developed are 
helping to· eliminate this deficiency. 
Although the major obstacle which researchers face in 
their attempt to develop RIA for proteins and peptides is 
18 
in the isolation of the pure compound, the main problem con-
fronting those developing RIAs for drugs and steroids is in 
the production of a suitable antisera. These compounds are 
rendered immunogenic by chemically coupling them to a larger 
I 
antigenic molecule. This usually involves the formation of 
a peptide bound between the drug or steroid and the protein, 
usually but not always, bovine serum albumin (BSA). The 
point of conjugation often has an important influence on the 
degree of specificity of the antibody produced; this is 
especially true with steroids. It has been only in the last 
five years that highly specific, low cross-reacting, anti-
bodies have been produced utilizing immunogens conjugated at 
different points on the haptene molecule (Ekins, 1974). An-
other difficulty encountered when dealing with these com-
pounds is that most cannot be radioiodinated directly. This 
difficulty is overcome by the use of 14c- or 3tt-labelled 
drugs or steroids. Currently drugs or steroids are being 
coupled to compounds containing a p-hydroxyphenyl group that 
can be radioiodinated (Hunter, 1974). 
As stated above a major problem with steroid RIA is 
the cross-reactivity of related steroids with the antibodies 
produced (James, 1974). For example in the RIA of testos-
terone the major cross-reacting steroid is dihydrotestos-
terone which initially showed a 100% cross-reactivity with 
antisera manufactured by New England Nuclear (NEN, 1975). 
This cross-reactivity has recently been reduced to 56% 
through production of antisera to a different conjugate. 
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This problem is also evident in the RIA of the estrogens. 
Here the three major estrogens: estradiol, estrone and 
estriol all cross-react significantly with antisera pro-
duced against an estradiol conjugate. When dealing with 
the measurement of these steroids, it is sometimes neces-
sary, depending on the specificity required, to fraction-
ate the sample extract by column chromatography prior to 
the assay. With increased antibody specificity the chroma-
tographic step can be eliminated (Castro, 1973; Stahl, 1975 
and Sheldon, 1977) which is desirable when dealing with 
small samples. 
Many of the RIAs developed for pharmacology also have 
a potential for use in the forensic sciences. Those RIAs 
developed for morphine and opiate alkaloids, lysergic acid 
derivatives, tetrahydrocannabinol (cannabis), barbituates 
and other drugs of abuse provide a screening method to de-
tect the particular drug in a suspected abuser, in an over-
dose case or in blood samples found at a crime scene. 
Blood or bloodstains are one of the most frequently 
encountered types of evidence at crime scenes; especially 
crimes of the mo~t serious nature such as homocides, as-
saults and rapes (Saferstein, 1977). The determination of 
other marker systems in these samples, such as sexual ori-
gin, will complement the evidence provided by the identifi-
cation of the major blood factors. As stated previously 
the RIA method offers an accurate and sensitive method for 
sex determination based on the quantity of testosterone and 
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estrogens present in a quantity of bloodstained material. 
Because the steroid molecule is highly stable (Morrison, 
1973) it is capable of withstanding the effects of drying 
in a bloodstain. The proper preparation and extraction 
of the stain with ether enables the investigator to mea-
sure each steroid fairly accurately. The results obtained 
are then calculated as a ratio for each sample and used 
as a basis for discriminating between male and female 
samples. 
When working with any RIA method it is essential to 
know the limits of the antibody being employed, especially 
in reference to its cross-reactivity with compounds other 
than the one which is being measured. In working with 
blood it is not uncommon to have several compounds present 
in the extract, and therefore in the test system, which are 
capable of cross-reacting with the antibody and causing an 
overestimation of the quantity of the compound being mea-
sured (James, 1974). This would also be true when working 
with bloodstains since diethylether will extract from a 
bloodstain many _nf the organic soluble steroids present. 
The cross-reactivity of many of the naturally occurrin~ 
steroid hormones with the antisera used in this study has 
been reported by the manufacturer, New England Nuclear 
(protocols 1975, 1976). However, the question of cross-
reactivity of this antisera with synthetic steroid hor-
manes, used in oral contraceptives, has not been reported 
and is undertaken in this study. 
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The compounds ethinyl estradiol (EE 2 ), ethynodial di-
acetate, mestranol, norethindrone (NET), norgestrel (Nor-G) 
and norethylnodrel are the most commonly used synthetics 
in oral contraceptive preparations (Murad, 1975). The 
first and third are synthetic estrogens and the remaining 
four are synthetic progestins. Either group is capable of 
cross-reacting with the antiserum used in either the testos-
terone or estrogen assays (see Figures 2 and 2A) . 
The literature available on these compounds is exten-
sive and a good review of their metabolism has been pub-
lished (Ranney, 1977). EE2 , NET and Nor-Gare the most 
representative of this group since mestranol is converted 
to EE2 and the others to NET in vivo. Reports concerning 
the plasma concentration of these drugs after administra-
tion is limited. This information is necessary in order 
to perform significant studies dealing with cross-reactiv-
ity. Verma (1975) reports the plasma levels to range from 
144 to 248 pg/ml after 6 hours in women receiving 50ug of 
EE2 or mestranol, through the use of a competitive protein 
binding radioass~y for EE 2 . RIA procedures developed for 
NET (Nygren, 19ii and St~nczyk, 1978) show plasma l~vels 
to rise and fall rapidly and attain peak levels of approxi-
mately 15ng/ml within 1.5 hours after ingestion of a lmg 
dose. Finally, Brenner (1977) reported levels of Nor-G, 
as determined by RIA, to range between 8-12ng/ml plasma in 
women receiving 500ug per day for twenty-one days. 
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The normal daily dose for each of these compounds as 
reported by Murad (1975) are as follows: EE2 : 20ug to 
lOOug with an average of SOug; NET: 500ug to 10,000ug with 
an average of l,OOOus; Nor-G: 75ug and 500ug. 
In addition to their cross-reactivity potentials these 
compounds could affect the assay in another way. Briggs 
(1976) has reported that the administration of these syn-
thetic hormones cause changes in the estradiol fluctuations 
seen in the female cycle. In women being administered 
these preparations there are no estradiol peaks observed, 
due to LH suppression, although basal levels remain the 
same. These drugs affect progestrone levels in the same 
manner. Testosterone levels have been observed to increase 
slightly. In essence these drugs could cause an over or 
underestimation of the actual T and/or E levels present in 
a stain from a female who is taking such medication. 
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III. EXPERIMENTAL 
During the course of the study blood samples were ob-
tained from two groups of volunteers. The first group of 
twenty-four samples, obtained from twelve male and twelve 
females, constituted an open study in which the sex of each 
individual sample was known. The second group of sixteen 
samples, eight males and eight females, constituted a 
single-blind study where the number of male and female 
samples were known but the sex of each individual sample 
was not known until all assays were completed. The volun-
teers ranged in age between 18 and 27 years. 
All blood samples were drawn by a qualified medical 
technologist into 7ml EDTA vacutainer tubes to prevent co-
agulation. From each individual blood sample twelve whd le 
bloodstains were prepared by absorbing O. lml of whole blood 
onto 2X2cm square pieces of white cotton cloth and allow-
ing them to dry completely on a large flat piece of clear 
-~ 
glass. Each gro-;p of stains was then stored in labeled 
plastic bags. Assays were run simultaneously for testos-
terone and estrogen at three different intervals from the 
time of staining. The first assay was performed 48-72 
hours after the stains were made. The second and third 
assays were subsequently conducted at one and two month 
intervals. 
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The equipment, reagents and space required for the com-
pletion of this study were made available in the Department 
of Pharmacology and Toxicology at the University of Rhode 
Island. Special chemicals such as BSA, Fr. IV; gamma glob-
ulin, Fr. II; norit A, neutral; and dextran T-70 were ob-
tained from Sigma Chemical Company, St. Louis, Mo. All 
chemicals utilized were of reagent grade quality. Anes-
thetic grade ether, used for extraction of the samples, was 
obtained from the Department of Medicinal Chemistry at the 
University of Rhode Island. The pure synthetic steroids 
used in the cross-reactivity studies were supplied courtesy 
of Ortho Pharmaceutical Corporation, Raritan, N.J. (Ethynyl 
Estradiol, Mestranol and Norethindrone); Searle and Co., 
San Juan, Puerto Rico (Ethynodiol Diacetate and Norethy-
nodrel); and lfyeth Laboratories, Inc., Philadelphia, Pa. 
(Ethinyl Estradiol and dl-Norgestrel). 
Commercial RIA kits for testosterone and estrogens, 
sufficient for 500 tubes each, were obtained from New 
England Nuclear Biomedical Assay Laboratories, North 
Billerica, Mass. Each RIA kit consists of five vials of 
lyophilized antiserum, one vial each of tritium labeled 
steroid in organic solvent and steroid standard in buffer 
and a protocol which outlines the preparation of the com-
ponents and the basics for their use in a RIA determination 
in plasma or urine samples. The methods described for this 
study follow those outlined in the protocols with some modi-
fications. 
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The buffer and dextran coated charcoal systems used 
in each assay were freshly prepared prior to each assay. 
Their formulations are shown in Table 1. Prior to the use 
of the antisera in the RIA determinations they had to be 
reconstituted with the respective assay buffer to obtain a 
specific titer. The following rapid procedure was used 
for the titer determination and reconstitution of each 
antiserum. 
Five and 2.5mls of the proper assay buffer were added 
to the lyophilized vials of testosterone and estradiol anti-
sera, respectively. The vials were gently inverted several 
times over a 15-30 minute period to insure complete disso-
lution. Fifty and 25% dilutions were prepared by adding 
0.15 and 0.30ml of assay buffer to 0.15 and 0.10 ml ali-
quots of the concentrates. Eight 12X75mm disposable glass 
tubes were prepared in accordance with Table 2 for each 
antiserum. The tubes were mixed on a vortex genie and in-
cubated at 4°C for 24 hours. They were then placed in an 
ice bath and the proper cold dextran coated charcoal sus-
pension (under constant stirring) was added to all except 
tubes 1 and 2. The tubes were allowed to stand, on ice, 
for 5 minutes and then centrifuged under refrigeration at 
2700 rpm for 30 minutes. After centrifuging the tubes 
were put on ice and 0.5ml of the supernatant was trans-
ferred into scintillation vials containing 10 ml of Hydromix 1 
1 Hydromix is a trademarl< of Yorktown Research, Hackensack,, 
NJ. 
Table I 
Solutions for RIA 
Testosterone System 
Stock Solution 
NaH2P04·H20 
NaN3 
Dissolve in 900ml of 
distilled water.+ 
Adjust pH to 7.4-0.l 
with lN NaOH then 
q.s. to lOOOml with 
distilled water. 
Assay Buffer 
BSA Fr.V 
Stock solution 
Dilute to lOOOml 
13.Bg 
2.0g 
5.0g 
SOOml 
with distilled water. 
Estrogen System 
Assay Buffer 
NaH2P04·H20 
Na2HP04·7H20 
NaCl 
NaN3 
ll-Globulin Fr.II 
Dissolve in 900ml 
of distilled water. 
Adjust pH to 7.0~0.l 
with lN NaOH then 
q.s. to lOOOml with 
distilled water. 
5.38g 
16.35g 
9.00g 
1. OOg 
l.OOg 
Charcoal Solution 
NaCl 
Dextran T-70 
Norit A, neutral 
Dissolve in lOOml of 
stock solution. 
Charcoal Solution 
Dextran T-70 
Norit A, neutral 
Dissolve in lOOml ~f 
assay buffer solution. 
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0.900g 
0.025g 
0.250g 
0.025g 
0.250g 
Tubes 
1,2 
3,4 
5,6 
7,8 
Assay 
Buffe:r:.:1{'!~ 
1.0 ml 
0.1 ml 
0.1 ml 
0.1 ml 
ij~~ J;;\ t~ 
~'"". · 
Table 2 
Antiserum Titer Determination 
Dilution of Antiserum 
Assay Tracer Undiluted 1:1 1:3 
0.1 ml 
0.1 ml O.lml 
0.1 ml -- O.lml 
0.1 ml -- -- O.lml 
rv 
l..O 
3 0 
scintillation cocktail. The vials were capped tightly, 
vortexed and counted for tritium for ten minutes each. 
The percent radioactivity bound in tubes 3 through 8 
was then determined by reference to the average cpms of 
tubes 1 and 2. By plotting the dilution of antiserum ver-
sus the percent radioactivity bound (Figure 3), the proper 
dilution to obtain 40-50% binding was determined. The re-
mainder of the original concentrate, and other vials of 
lyophilized antiserum with the same lot number, were di-
.luted to the appropriate volume. The reconstituted anti-
serum was stored at 4°C and mixed well prior to use in 
each assay. In this form the antiserum is stable for ap-
proximately two months. Indications of deterioration are 
a sharp drop in binding from previous levels or a signif i-
cant change in the sensitivity of the standard curve 
(McArthur, 1970 and NEN, 1975). 
The tritium labeled tracer was supplied in a benzene-
ethanol (9:1) mixture at a specific activity of 305-450 
DPM/pg, or l.5uCi/ml, or approximately lOOOcpm/ul. The 
recovery tracer~as prepared by drying down an appropriate 
- ' 
aliquot of the tracer ·in a glass vial and redissolving it 
in assay buffer to obtain 700-lOOOcpm/0.lml. The assay 
tracer was prepared in a similar manner to obtain approxi-
mately 4000cpm/O.lml for the testosterone assay and 5000 
cpm/O.lml for the estrogen assay. 
The concentrated and diluted tracers were stored 
tightly capped at 4°C. This labeled antigen is stable for 
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at least two months under these conditions. Indications of 
deterioration are decreased binding, decreased recovery, or 
an increase in the RIA blank (nonspecific binding) (NEN, 
1975). 
Stock solutions of testosterone and estradiol were sup-
plied in assay buffer at a concentration of lOOng/ml. This 
material is stable for at least three months when stored 
at 4°C. A standard curve must be run with each assay to 
cover the range of concentrations anticipated in the un-
knowns. A series of standards were prepared from the stock 
solution by diluting O.lml of stock to l.Oml with assay 
buffer to obtain a concentration of lng/O.lml. This was 
labeled solution A and further dilutions were made up, as 
outlined in Table 3, to provide a range of standards appr6-
priate for the assays. 
The extraction of the artificially prepared blood-
stains were carried out in labeled 13Xl00rnrn disposable test 
tubes. From the twelve 2X2cm squares for each individual 
one was extracted for the testosterone assay and three were 
extracted for th~~ estrogen assay due to the nearly three-
't.f 
fold differences in plasma concentration (NEN, 1975). The 
remaining pieces were used in the age study assays. Prior 
to each extraction, O.lml of the appropriate recovery 
tracer was added to the pieces of cloth in the tubes and 
allowed to dry. The stains were then extracted with 2,2 
and lml portions of an organic solvent. Initially, methyl-
ene chloride was used for the testosterone extraction and 
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Table 3 
Standard Solutions 
Assay Concentration 
Solution Aliquot (ml) Buffer (ml) (ng/0.1 ml) 
A 0.1 stock 0.9 1. 00 
B 0.5 A 0.5 0.50 
c 0.6 B 0.4 0.30 
D 0.6 c 0.3 0.20 
E 0.5 D 0.5 0.10 
F 0.5 E 0.5 0.05 
G 0.6 F 0.4 0.03 
H 0.6 G 0.3 0.02 
I 0.3 H 0.3 0.01 
J 0.3 I 0.3 0.005 
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di~thyl ether for the estrogen extracti6n. However, the 
recovery with diethyl ether was greater than recovery with 
methylene chloride, so all future extractions were carried 
out using diethyl ether. The extract portions were then 
pooled for each s~mple into corresponding 13Xl00mm test 
tubes. The organic solvent was then taken to dryness ei-
ther in a vortex evaporator at 37°C under vacuum or by a 
stream of nitrogen gas. Two mls of absolute ethanol was 
then added to each tube and they were vortexed for com-
plete dissolution. 
The reconstituted samples were then divided into ali-
quots for use in the recovery determinations and the RIAs. 
A O.Sml aliquot was transferred to and dried down directly 
in scintillation vials. Ten mls of Hydromix1 scintilla-
tion cocktail and O.lml of the appropriate buffer were then 
added, the vials were capped, vortexed and counted for ten 
minutes each. The cpms obtained for each were compared 
with the average cpms for two vials which contained O.lml 
of the recovery tracer and lOml of scintillation cocktail, 
the total recove.;,o/ standard, to determine the perc"; ,nt of 
steroid recovery. 
The actual assays were carried out in 12X75mm dispos-
able t e st tube s (RIA tube s) . Each sampl e wa s prepared in 
duplicate by transferring two aliquots to labeled duplicate 
1 Aquassure scintillation cocktail was used when Hydromix 
was unavailable. Aquassure is a trademark of the New England 
Nuclear Corporation, Boston, Mass. 02118. 
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RIA tubes. These samples were dried down by a stream of 
nitrogen. Total count, blank, zero standard, steroid stan-
<lards and the sample tubes were then prepared as outlined 
in Table 4. The incubation of all tubes at 4°C lasted for 
18-20 hours. Following incubation the tubes were placed 
in an ice bath and the proper amount of the appropriate 
dextran coated charcoal solution was added to only as many 
tubes as could be centrifuged at one time. The charcoal 
solution is not added to any of the total count tubes. Af-
ter a five minute period, on ice, these tubes were centri-
fuged at 4°C for 30 minutes at 2700rpm in a bucket-type 
centrifuge. Upon completion of centrifugation equal por-
tions of supernatant from each tube were placed in labeled 
scintillation vials containinq lOmls of Hydromix1 scintil-
lation cocktail. The vials were tightly capped, vortexed 
and counted for tritium for 10 minutes each. 
A total of fourteen separate assays were conducted us-
ing this procedure. Three testosterone and three estrogen 
assays were performed in each of the open and single blind 
studies at 2, 30 and 60 days after the preparation of the 
~ 
bloodstained samples. Two assays were conducted to test 
the cross-reactivity of certain synthetic steroids with the 
testosterone and estradiol antiserums. 
After the completion of both the open and single-blind 
studies the cross-reactivity study, concerning the synthetic 
1Aquassure scintillationcocktail was used when Hydromix 
was unavailable. Aquassure is a trademark of the New England 
Nuclear Corporation, Boston, Mass. 02118. 
Table 4 
RIA PROTOCOL 
Anti-
Assay Standard or Assay2 serum
3 Charcoal 
1 Buffer (ml) Sample (ml) Tracer (ml) (ml) Suspension ~·f E E Both T E T Tube 
.to; ·~ T E r "' . , 
Total Amount 1. 0 1.20 -- -- 0.1 
Blank 0.2 0.15 -- -- 0.1 -- -- 0.8 1.0 
Zero Std. 0.1 0.10 -- -- 0.1 0.1 0.05 0. 8 1.0 
All Stds. 4 -- -- 0.1 0.1 0.1 0.1 0.05 0.8 1.0 
All Samples 0.1 0 .10 (0.5) 5 (0.6) 5 0.1 0.1 0.05 0.8 1.0 
1All tubes run in duplicate. 
2The assay tracers were prepared at 4000 cpms for the open and single-blind stu-
dies and at 10 4 cpms for the cross-reactivity study. 
3Antiserum is added last in every case. All tubes were incubated at 4°C for approxi-
mately 24 hours. 
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standards B-J f{om Table 3 were used in all three studies. The concentrations of 
synthetic steroi1'.<;!~ shown in Tables 5 and 6 were treated as standards in the cross-
reactivity study. 
5
nried down aliquots of the ethanol reconstituted extracts. 
w 
\.;, 
steroids mentioned previously, was undertaken. The six syn-
thetic steroids supplied to us, through the various pharma-
ceutical companies mentioned, were each weighed to the near-
est O.Olmg. Each was dissolved in an appropriate volume 
of a benzene:ethanol (9:1) solution to obtain a concentra-
tion of lmg/ml. These stock solutions were appropriately 
labeled and serially diluted as outlined in Tables 5 and 6 
to give ranges of concentrations which would be suitable 
for use in the crbss-reactivity studies. 
The determination of the cross-reactivity of these syn-
thetic steroids was accomplished in two separate assays with 
the testosterone and estradiol antiserums. Each of the six 
steroids, in the concentration ranges shown in Table 5, were 
tested against the estradiol antiserum. The assay of these 
compounds were run concurrently with a set of estradiol 
standards prepared as shown in Table 3. In the cross-
reactivity studies with the testosterone antiserum, there 
was a need to conserve some of the components of the testos-
terone RIA kit and therefore only three representative syn-
thetic steroid~~' EE 2 , NET and norgestrel were te~ted. The 
ranges of concentrations shown in Table 6 were assayed con-
currently with a ~et of testosterone standards (Table 3). 
The protocol for the cross-reactivity study is the same as 
outlined in Table 4 for the other two studies. 
Solution 
A 
B 
c 
D 
E 
F 
G 
H 
I 
J 
K 
L 
Table 5 
Synthetic Steroid Standards for the 
Estradiol Cross-Reactivity Study 
Assay Concentration 
Aliquot (ml) Buffer (ml) (ng/O .1 ml) 
0.1 ml stock 1 10.0 1000.0 
0.5 A 0.5 500.0 
0.6 B 0.4 300.0 
0.6 c 0.3 200.0 
0.5 D 0.5 100.0 
0.5 E 0.5 50.0 
0.6 F 0.4 30.0 
0.6 G 0.3 20.0 
0.5 H 0.5 10.0 
0.5 I 0.5 5.0 
0.6 J 0.4 3.0 
0.6 K 0.3 2.0 
--~. 
-
~ ~~ 1The stock solutions of each of the SlX synthetic 
steroids at a concentration of lmg/ml in a benzene: 
ethanol ( 9: 1) solution were dried down prior to addi-
ti on of assay buffer. 
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Table 6 
Sy nthetic Steroid Standards for 
Testosterone Cross-Reactivity Study 
Ethinyl Estradiol 
] 8 
Solution Aliquot (ml) 
Assay 
Buffer (ml) 
Concentration 
(ng/0.1 ml) 
A 
B 
c 
D 
E 
A 
B 
c 
D 
E 
0 . 1 Stock 1 0.9 
0.6 A 0.4 
0.6 B 0.3 
0.5 c 0.5 
0.5 D 0.5 
Norethindrone and Norgestrel 
2 0.1 Stock 
0.75 Stock 
0.5 A 
0.5 c 
0.4 D 
4.9 
4.925 
0.5 
0.5 
0.6 
0.50 
0.30 
0.20 
0.10 
0.05 
20.0 
15.0 
10.0 
5.0 
2 . 0 
1 ~ -The stock sol~ ion for EE2 contained 5ng/O.lml as£ay buffer. 
2Th e stock solutions for NET and Norgestrel contained 
lOOOng/O.lml assay buffer. 
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IV. RESULTS 
The original data obtained from the various studies 
were in terms of counts per minute (cpm) of radioactivity 
as determined in a Packard Tri-Carb Liquid Scintillation 
Spectrometer Model 3310. CPMs for duplicate tubes were 
averaged and all counts were corrected for background in-
terference by subtracting the blank values obtained for 
the same counting session. The appropriate net cpms were 
then manipulated through the use of the equations shown 
in Appendix A to determine: 1. The fractional recovery 
of testosterone (T) or estrogen (E) from the extraction 
of the bloodstained samples (Eq. I), 2. the percent radio-
activity bound in the assay of the standards, samples and 
synthetic steroids (Eq. II), and 3. the amount of each 
steroid (ng) per bloodstained sample (Eq. III). 
Titer determinations were made on three different lots 
of antiserum (one T and two E). Duplicates were averaged, 
corrected for background and the percent bound det'.~rmined 
by reference of the antiserum containing samples to the 
total count samples. The percent bound was then plotted 
against the antiserum dilution to produce the graphs shown 
in Figure 3 . The various lots of antiserum were diluted, 
as needed, to those proportions on the proper curves which 
produce between 40 and 50% binding. 
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Fra ctional recoveries were determined for each sample 
assaye d within the open and single-blind studies (Eq. I). 
The individual values obtained were used in the determina-
tion of the actual amount of T or E present in the original 
bloodstained sample (Eq . III). The average fractional re-
covery and standard error (S.E.) were determined for each 
of these assays. These averages, in Table 7, show the over-
all recovery of 'I' andEto be 64.3% and 68.8%, respectively. 
The percent of radioactivity bound was determined for 
the standards, samples and synthetic steroids in every assay 
(Eq. II). The values for each standard were plotted 
against the corresponding log-dose of the steroid (ng) on 
semi-logarithmic paper . The resulting standard curves are 
displayed in Figures 4-15. Figures 4-13 correspond to the 
age group of the samples assayed in the open and single-
blind studies and are labeled accordingly . Figures 8 and 9 
were used for both the 60 day old samples of the open study 
and the 2 day old samples of the single-blind study since 
the assays for these groups were performed concurrently. 
The standard curves for the cross-reactivity studies (Fig-
• -~ 
ures 14 and 15) were plotted along with the curves obtained 
for the synthetic steroids tested, since each synthetic 
s t eroid was t reated as a standard. 
Amounts of T and E in the extract aliquot assayed for 
each sample were determined by interpolation from the 
proper standard curve. These values were adjusted to give 
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Table 7 
Average Fractional Recovery and Standard Errors 
Open Study 
Testosterone Extract Estrogen Extract 
0.465 + 0.010* 0.751 + 0.004 
0.745 + 0.019 0.727 + 0.006 
0.922 + 0.014 0.960 + 0.012 
Single-Blind Study 
Testosterone Extract Estrogen Extract 
0.757 + 0.018 0.684 + 0.033 
0.173 + 0.009 0.274 + 0.013 
0.798 + 0.017 0.732 + 0.027 
* This extraction was performed using methylene chloride. 
All other extractions were performed using diethyl ether. 
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the amount of T or E in the original bloodstained sample by 
taking into account: 1. the relative amount of blood-
stained material extracted, 2. the functional recovery of 
the sample, 3. the reconstituted volume of the extract, and 
4. the amount of that volume used in the assay (Eq. III). 
These adjusted values were put into ratio form (T:E) for 
the same sample at each age. The resulting ratios for all 
samples at each age group are shown in Tables 8 and 9 from 
the open and single-blind studies, respectively. 
The T:E ratios from the single-blind study were used 
to determine the accuracy of this method to predict the 
sexual origin of the bloodstained samples in this study at 
each age level. Since it was known that the numbers of 
male and female donors for this study were equal (eight), 
the ratios were independently divided into two equal groups 
at each age .level. The higher values were designated as 
male and the lower values as female. These designations 
were then compared with the correct sexual origin of each 
sample. It was found that the selections correctly desig-
nated within tha _2, 30 and 60 day age levels were ,;,# '%, 62.5% 
. '"' 
and 50% correct, respectively. A test for significance of 
a proportion was used to determine which of the percentages 
were significantly different from an expected 50% correct, 
since this was a single-blind study. The percent correct at 
the 2 day age level was the only value shown to be signifi-
+ cant (z=2, critical z_ 05 = -1.96) within a 95% confidence 
leve 1. 
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Table 8 
T:E Ratios for Open Study 
Age of Bloodstains (days) 
Sample # 2 30 60 Sex 
1 34.76 16.14 0.088 M 
2 32.67 12.35 0.159 M 
3 32.40 12.31 0.224 M 
4 38.71 1.94 0.042 M 
5 41. 80 11. 94 0.054 M 
6 79.25 11. 53 0. 0 62 M 
7 57.08 12.25 0.190 M 
8 41. 69 3.41 0.136 M 
9 62.45 6.17 0.281 M 
10 49.67 9.23 0.364 M 
11 27.90 6.15 0.209 M 
12 41.70 5.06 0.233 M 
13 3.03 1. 05 0.450 F 
14 3.80 0.90 0.419 F 
15 1. 61 1. 95 0.545 F 
16 1.77 1.00 0.307 F 
17 3.07 0.43 0.144 F 
18 0.50 0.58 1.183 F 
19 0.36 0.26 0.374 F 
20 1.10 0.32 0.918 F 
21 0.00* 0.89 1.567 F 
22 0.00* 1.16 0. 795 F 
23 0.45 1.21 0.378 F 
24 1. 30 0.98 0.453 F 
detected in these samples. 
Table 9 
T:E Ratios for Single-Blind Study 
Sample # 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
* Testosterone 
Age 
2 
1. 95 
2.14 
2.23 
2.33 
4.37 
2.29 
2.79 
3.04 
2.45 
2.69 
1. 40 
1. 4 7 
0.60 
1. 50 
3.22 
2.67 
of Bloodstains (days) 
30 60 
0.18 0.12 
3.94 0.09 
3.32 0.12 
0.67 0.03 
0.49 0. 2 0 
1. 24 0.07 
0.85 0.15 
0.45 0.16 
0.51 0.09 
0.34 0.11 
0 . 62 0.15 
0.38 0.20 
0.71 0.18 
0.00* 0.57 
2.19 0.67 
1.88 0.09 
· detected in this sample. 
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Sex 
F 
.M 
M 
M 
M 
F 
M 
M 
F 
F 
F 
F 
F 
F 
M 
M 
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,. rurther statistical analysis of the T:E ratios for both 
the open and single-blind studies included T-tests for dif-
~erences between male and female samples at each age level 
and between each a9e level within each sex. The results of 
each T-test are displayed in Tables 12 and 13 (Appendix B) . 
Analysis of variance (ANOVA) , based on a two-way mixed de-
sign, was also performed on the mean T:E ratios (Table 10) 
from each study. The ANOVA analysis should demonstrate: 
1. whether there was a significant difference between male 
. and female ratios, (conditions) , 2. whether there was a sig-
nificant difference between ratios for the same samples at 
different age levels (trials) and 3. whether there was a sig-
nificant interaction between the age of the sample and the 
distinction between male and female samples (trials x condi-
tions) . The source tables for each ANOVA are contained in 
Appendix C (Tables 14 and 15). 
The T-test analysis for differences between males and 
females showed that there was no significant difference be-
tween male and female ratios only at the 60 day age level in 
confidence level. _g.Jn the 
,, 
T-test analysis for differences between age levels several 
comparisons shov-.Bd no significant difference at a 95% confi-
dence level . In the open study there was no significant 
difference bet,:ween all age comparisons for female ratios. 
In the blind study no significant difference was seen be-
tween the 2 and 30 day age levels for male ratios or between 
the 30 and 60 day levels for the female ratios. 
5 1 
Table 10 
Mean T:E Ratio Values and Standard Errors 
Open Study 
Age (Days) Males Females 
2 45.01 + 4.29 1.42 + 0.52 
30 9.04 + 1.34 0.89 + 0.14 
60 0.17 + 0.029 0.63 + 0.12 
Single-:-Blind Study 
2 2.85 + 0.26 1.79 + 0.24 
-
-
30 1. 72 + 0.48 0.50 + 0.13 
-
60 0.19 + 0.07 0.19 + 0.06 
-
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ANOVA of the mean T:E ratios from the open study showed 
significant differences (p=0.05) between males and females 
at each age level and also between the same samples at dif-
ferent age levels. There was also a significant interaction 
between these two factors. For the single-blind study, 
ANOVA showed significant differences (p=0.05) between males 
and females at each level and also between the same samples 
at different age levels; however, no significant interaction 
occurred between these two factors. 
The results from the cross-reactivity study were 
handled in a slightly different manner than the results from 
the other two studies. Instead of comparing the cpms of the 
standard and synthetic steroid samples to the total counts, 
they were compared to the zero standard counts to indirectly 
determine the percent of displacement of labeled antigen 
from the antiserum (Eq. II). The percentages obtained for 
each standard and synthetic steroid were then plotted 
against the corresponding log-dose of the steroid added (ng) 
on semi-logarithmic paper. The curves obtained in the testes-
terone cross-r~a~ivity for testosterone, ethinyl estradiol, 
norethindrone and norgestrel are displayed in Figure 14. 
The curves obtained in the estradiol cross-reactivity study 
for estradiol, ethinyl estradiol, mestranol, norethindrone, 
norethynodrel, norgestrel and ethynodiol diacetate are dis-
played in Figure 15. 
The percent of cross-reactivity any compound shows with 
an antiserum is determined at 50% displacement of the 
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labeled antigen. The amount of the target antigen needed 
to displace 50% of the labeled antigen is divided by the 
amount of the compound in question needed to displace the 
same amount of labeled antigen. This value is then multi-
plied by 100 to obtain the percent cross-reactivity at 50% 
displacement. 
Only one of the synthetic steroids tested showed 50% 
displacement at the concentrations tested (Table 11). 
Ethinyl estradiol showed a 5.00% cross-reactivity with the 
estradiol antiserum. The other compounds tested showed 
less than 0.01% cross-reactivity with either the testoster-
one or estradiol antisera. 
Table 11 
Cross-Reactivity of Steroids 
Percent Cross-Reactivity at 50% Displacement 
Compound 
Testosterone* 
Dihydrotestosterone* 
Estradiol-17a* 
Estrone* 
Estradiol-17!3* 
Estriol* 
Ethinyl Estradiol 
Mestranol 
Norgestrel 
Norethindrone 
Norethynodrel 
Ethynodiol Diacetate 
T-Antiserum 
100.00 
56.00 
0.10 
0.05 
0.05 
0.05 
NS** 
NS** 
NS** 
E-Antiserum 
0.001 
100.00 
50.00 
25.00 
5.00 
5.00 
NS** 
NS** 
NS** 
NS** 
NS** 
Values for these compounds were taken from the Protocols 
supplied with RIA kits. 
** NS- Not significant at the therapeutic level or at 
higher levels tested (less than 0.01% cross-reactivity). 
(i 2 
V. DISCUSSION 
The basic principle underlying this study is the well-
established endocrinological differences between males and 
females in terms of the levels of two particular steroid 
hormones--testosterone and estrogen. Besides the basic dif-
ference in the levels .of these hormones between the sexes, 
the levels are affected by age, physical condition and by 
certain drugs. 
Testosterone is formed in the interstitial cells of the 
Leydig region in the male testes. In females testosterone 
is produced as an intermediate in estrogen synthesis and in 
the reduction of androstenedione and adrenal corticosteroid. 
It is normally secreted by the female ovaries in minute 
amounts. Levels of testosterone are relatively low in male 
children and in most females. Testosterone appears in sig-
nificant quantities in newborn males and in adult males any 
time after pube ~:t:y. These levels begin to dwindle in males 
after age 40, ana decrease to about one-fifth the peak level 
by age 80. 
In normal nonpregnant females estrogens are cyclically 
secreted by the ovaries, with minute amounts secreted by 
the adrenal cortices. During pregnancy tremendous quantities 
are also secreted by the placenta, up to fifty times that 
secreted by the ovaries during a normal cycle. In males, 
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estrogens are present at about one-fifth the level found in 
nonpregnant females. Estrogen in males is produced during 
the reduction of testosterone and may also be produced in 
the seminiferous tubules and interstitial cells. Levels of 
estrogens are relatively low in female children and they 
begin to ·rise and fall in a cyclic pattern after puberty. 
Estrogen levels begin to taper off at menopause (age 40-50) 
and approach zero after menopause. 
The experiments in this study were designed to deter-
mine the limitations involved in applying the RIA technique 
in the forensic sciences for the purpose of identifying the 
sexual origin of a bloodstain utilizing the hormone prin-
ciple. The experiments were devised to test several aspects 
of this application. Both the open and single-blind exper-
iments tested the capability of commercially available RIA 
kits to quantitate testosterone and estrogen in extracts of 
prepared bloodstains and determined whether the age of a 
bloodstain affects that quantification. The single-blind 
study also allowed a determination to be made on the accur-
acy of using ratio as a basis for discriminating 
between male and female bloodstains. The cross-rem:::tivity 
study became an essential part of this study because of the 
possible presence of synthetic steroids in bloodstains from 
a source such as oral contraceptives. This experiment pro-
vided an indication of the possible interference these 
steroids might cause by reacting significantly with the 
antiserum used in the RIA techniques. 
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The recovery results from each assay showed that ster-
oids are easily recovered from bloodstains when extracted 
with diethylether. The average recovery for both testoster-
one and estrogen was about 70% or better (Table 7). In 
three assays the recoveries were less than 50%. In the 
testosterone assay of the 2 day open study the recovery was 
only 46.5%. This extraction was performed using methylene 
chloride. Both testosterone and estrogen assays of the 30 
day single-blind study showed less than 30% recovery for un-
known reasons. In the clinical use of these RIA kits, re-
coveries of less than 40% are considered too low and should 
be repeated; however, in this study this was no~ possible 
and the assays were carried out as usual. 
Radioimmunoassays of the sample extracts produced data 
which indicated that significant amounts of each steroid 
are detectable. These amounts were adjusted accordingly 
and put into ratio form, T:E (Tables 8 and 9), for compari-
sons. The adjusted levels detected for the samples showed 
that testosterone levels ~re within the ranges reported 
' I 
for males and females in all but the 60 day study ~o~ both 
·--~ 
experiments where testosterone levels were well below those 
ranges. Estrogen levels were above reported ranges in all 
assays on male samples and in three of the six assays on 
female samples. This may be due to a higher degree of 
cross-reactivity (total estrogen) in the estrogen RIA than 
in the testosterone RIA. 
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Comparisons were made within each experiment using the 
ratios to determine whether there was a significant differ-
ence between male and female ratios and if there was a sig-
nificant difference between bloodstains at different age 
levels (2, 30 and 60 days), which were prepared from the 
same blood source. Analysis of variance, two-way mixed de-
sign, demonstrated that: 1. there was a significant 
(p 0.05) difference between male and female ratios, 2. the 
age of a bloodstain influences the amount of steroids de-
tected, and 3. in the open study experiments the age of the 
bloodstain affected the ability to distinguish between male 
and female ratios. This interaction of the two major fac-
tors of sex and bloodstain age was not seen in the single-
blind study which may be due to another time factor: the 
age of the RIA kits. 
T-tests were conducted to determine whether any indi-
vidual comparisons were not significantly different as in-
dicated by ANOVA. In male vs. female comparisons only the 
60 day single-blind study was not significant, which again 
may be due to t:~ · age of the RIA kits. For compar~sons of 
~ -
samples from the same blood source at different bloodstain 
age levels there ~re five comparisons which were not sig-
nificant. There was very little consistency between the 
open and single-blind studies in terms of the significance 
or nonsignificance of a particular comparison. However, it 
was observed that values for female bloodstains showed less 
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variations between the three age levels (2, 30 and 60 days) 
tested than that seen for the male bloodstain values. 
From the ratios obtained in the single-blind study de-
terminations were made at each age level on the accuracy of 
predicting the sex of a particular sample. The accuracy de-
creased as the age of the bloodstain increased with only the 
75% accuracy at the 2 day level being significant. This ac-
curacy may also be affected by the age of the RIA kit. 
Clinically the RIA kits have a useful life of 3-4 
months. The time involved in completing all assays in this 
study required approximately 6 months. Therefore, the as-
says in the single-blind study were accomplished during the 
outer limits of the RIA kits' clinical life. This could 
explain the dramatic differences seen between ratios from 
the two experiments. In the open study the ratios at the 
2-day level are much higher than those from the 2 day single-
blind study. However, the ratios from the 2 day single-
blind study were between those from the 30 and 60 day open 
study ratios. A supporting fact for this time factor may be 
seen in the prepared for each ass a~ ~ An in-
* 
di cation of deterioration is a shift in the standa~d curve 
to the right. This shift is seen to a slight extent when 
comparing the standard curves (Figs. 4-13). Another factor 
which would affect these values was the dilution of the anti-
serum. For most cases the dilution should produce between 
40-50% binding but, this was not the case in all assays. 
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In imrnunoassays the rule is that the more dilute the anti-
serum the more sensitive the assay. Therefore, when the 
dilution produced greater than 50% binding the assay was 
less sensitive than if the dilution showed 40% binding. 
The cross-reactivity experiment showed that there is 
very little direct interference from synthetic steroids. 
Only ethynyl estradiol showed any significant cross-
reactivity with the estradiol antiserum. However, these 
steroids may have significant indirect effects, since they 
have been shown to decrease the total endogenous estrogen 
while they cause slight increases in testosterone. This be-
comes important in women who are taking oral contraceptive 
preparations. In the open study care was taken to take 
blood samples from women who were not taking these prepara-
tions. However, in the single-blind study the female donors 
were not selected on this basis and it was not known whether 
or not any of thes_e subjects were taking such medication. 
This rnay also have affected the female ratios to some ex-
tent, in the single-blind study. If the estrogen levels 
are decreased w~le testosterone levels are increqs~d a fe-
male sample may have been identified as male due to an ele-
vated T:E ratio. 
A study of this kind attempts to open a new line of 
identification to the forensic serologist. Although there 
are several markers which are readily identified there is 
a great need for detection of other markers which further 
() <) 
ide ntify the individual from whom a bloodstain originat'ed. 
With the development of specific antisera the identification 
of several genetic markers is easily accomplished. This 
principle can also be applied to physiological factors which 
vary as a result of genetic programming. To this end this 
initial investigation was devised to apply such techniques, 
through RIA methodology, for determining the sexual origin 
of a bloodstain based on the amounts of testosterone and 
estrogens detected. 
The limitations of this particular study lie in the 
time factors involved. The effects of age in terms of the 
age of the bloodstain, the age of the person from whom the 
blood sample was obtained and the age of the RIA kits util-
ized, have been discussed. The first two are beyond the 
control of the investigator and the third must be carefully 
monitored in order to have consistence between investiga-
tions. It is recommended that future studies utilize 
larger numbers of subjects as blood sources and that the 
subjects be screened as to whether they are taking specific 
medication, which 
with the RIAS . In this way a true indication could be made 
as to the accuracy of this method in both the presence and 
absence of interfering substances . It is hoped that this 
study will contribute to making this p r ocedure as common in 
the forensic laboratory as are the procedures for identify-
ing the components of the ABO system. 
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VI. SUMMARY AND CONCLUSIONS 
An investigation -wasmade concerning the ability of com-
mercially available RIA kits to quantify testosterone and 
estrogens in extracts of dried bloodstains, for the purpose 
of determining the sexual origin of those bloodstains. 
Whole blood obtained from male and female volunteers, was 
used to prepare twelve bloodstains on pieces of 2 X 2 cm 
white cotton linen, for each blood sample. Bloodstains 
were extracted and RIA carried out on the extracts at 2, 
30 and 60 days after their initial preparation. Resulting 
·values for testosterone and estrogen from each extract were 
put into T:E ratios. Ratios were compared for male vs. fe-
male differences and also for differences between samples 
from the same blood source at the three (2, 30 and 60 days) 
age levels. The accuracy for discriminating between blood-
stains from male and female sources and the direct inter-
ference of several synthetic steroids were also determined 
for this appli€~}ijion of the RIA technique. 
A significant difference was seen between ratios from 
male and female sources in five of the six comparisons. 
Only the final comparison, 60 day single-blind assay, showed 
no significant difference between male and female blood-
stains. There was also a significant difference between 
ratios for bloodstains from the same source at the different 
71 
time intervals (2, 30 and 60 days). Time was also signifi-
cant in terms of the age of the RIA kits, since there was 
an obvious difference between ratios determined for the 
bloodstains in the open and single-blind studies. The ac-
curacy of this method was shown to be 70% or less in the 
single-blind study. Direct interference from the synthetic 
steroids was minimal with only one compound, ethynyl estra-
diol, showing any significant cross-reactivity (5%) with 
the estradiol antiserum. 
The RIA method then is a potentially useful tool with 
applications in the forensic sciences. For the purpose of 
sexual identification the RIA techniques needed are readily 
available from commercial sources. From this study it has 
been demonstrated that: 1. the RIA kits are capable of 
quantifying the amounts of testosterone and estrogen present 
in extracts of bloodstains, 2. the T:E ratio serves as a 
fairly accurate basis for discriminating between male and 
female samples, and 3. the synthetic steroids tested have 
no direct significant effect on the RIA results. It was 
also shown procedure is subject to seve~ limita-
tions, the major one being time in terms of the age of a 
bloodstain, and the age of the RIA kit. A financial limita-
tion arises out of the need to use fresh kits for sensitivity 
and accuracy in this method, since sensitivity decreases as 
the age of a RIA kit increases. 
Also one must consider the indirect effects of the syn-
thetic steroids on the RIA results, since endogenous levels 
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of estrogen and testosterone are affected . This may also 
ha~ influenced the accuracy determinations from the single~ 
blind study. Finally, a double - blind study in which medical 
information is available might produce more significant 
data. Further investigation of these factors is therefore 
warranted. 
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APPENDIX A 
Equations 
I Fractional Recovery (FR) : 
FR= Net cpm for sample x 4* Average net cpm for total recovery standards 
II Percent Radioactivity Bound (% B): 
%B= Corrected cpm standard, sample or syntheticXlOO 
Corrected total count*~ 
III Steroid Concentrations of Samples: 
(ng from curve) x 2*** 
= ng steroid/sample 
Fractional .x Aliquot x Sample 
Recovery Assayed Extracted 
ml 
* Since one-fourth of the reconstituted extract is counted. 
** Corrected zdro standard count was used for standard and 
synthetic steroid counts in the cross-reactivity study. 
*** Since the dri e d extract is reconstituted to 2.0ml with 
absolute ethanol . 
• 
Open Study 
Single-Blind 
Study 
2 30 
6.04 
2.46 
APPENDIX B 
Table 12 
T-Test Analysis for Sex 
Sample Age (days) 
60 
3.83 
0.31* 
*Not significant at the 0.05 level. 
Table 13 
T-Test Analysis for Age 
Age Comparisons (days) 
2 vs 30 2 vs 60 JO vs 60 
Open Study M 8.16 10.45 6.98 
F 1.36* 1.68* 1.44* 
M 1. 72* 11.21 3.20 
Single-Blind hi", ·:,~ 
Study p ·~··1 ~~ 4.74 2.71 1.68* 
*Not significant at the 0.05 level. 
df 
22 
14 
df 
11 
7 
Critical t.05 
2.074 
2.145 
critical t.05 
2.201 
2.365 
-..J 
~ 
.. 
' 
APPENDIX C 
Table 14 
Analysis of Variance 1 Source Table-Open Study 
Source SS df MS F 
Total 21452.16 71 
Between Subjects 6167.05 23 
Conditions (M, F) 5258.76 1 5258.76 127.36 
Error 908.29 22 41.29 
Within Subjects 15289.11 48 
Trials (2,30,60) 6993.04 2 3496.52 18.57 
Trials X Conds. 6541.59 2 3270.80 17.37 
Errors 8283.68 44 188.27 
Table 15 
Analysis of Variance1 Source Table-Single-Blind Study 
Source 
Total 
Between Subjects 
Conditions (M, F) 
Error 
Within Subjects 
Trials (2,30,60) 
Trials X Conds. 
Error 
l M' d . Two-Way ixe Design 
2
s-Significant at the 
NS-Not significant at 
SS df 
68.24 45 
11. 39 15 
6.95 1 
4.44 14 
56.85 30 
36.64 2 
3.52 2 
16.69 26 
(Bruning, 1968). 
0.05 level. 
the 0.05 level. 
MS F 
6.95 21.92 
0.32 
18.32 28.54 
1.79 2.79 
0.64 
P2 
s 
s 
s 
2 p 
s 
s 
NS 
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